CENTURY THERAPEUTICS INC (IPSC)
US15673T1007 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to IPSC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.86. This target is 821.5% above the current price.
IPSC was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about IPSC.
In the previous month the buy percentage consensus was at a similar level.
IPSC was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-30 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-17 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-06-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-12 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-03-15 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-28 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2023-08-10 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-08-10 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-08-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-17 | EF Hutton | Maintains | Buy |
| 2023-04-13 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-22 | Chardan Capital | Reiterate | Buy |
| 2023-03-17 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-16 | EF Hutton | Reiterate | Buy |
| 2023-02-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-06 | EF Hutton | Maintains | Buy |
| 2023-01-06 | SVB Leerink | Maintains | Outperform |
| 2023-01-06 | Piper Sandler | Maintains | Overweight |
| 2023-01-06 | HC Wainwright & Co. | Maintains | Buy |
| 2023-01-05 | EF Hutton | Initiate | Buy |
| 2022-12-27 | Chardan Capital | Initiate | Buy |
| 2022-11-14 | HC Wainwright & Co. | Maintains | Buy |